Home › NDC Lookup › RxCUI directory › RxCUI 1544556

Neomycin sulfate 0.005 MG/MG Topical Ointment — RxCUI 1544556

RxNorm drug concept · Semantic clinical drug
RxCUI 1544556 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1544556
Official nameNeomycin sulfate 0.005 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asneomycin sulfate 0.5 % Topical Ointment; neomycin sulfate 5 MG/GM Topical Ointment
FDA products mapped3
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Neomycin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a first-aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and small burns. It's not meant for serious wounds or large areas of the...
  • Apply it directly to the affected area of skin. Follow the directions on your specific product label for how often to use it. As a general rule, don't use it for more than one week...
  • The main thing to watch for is a rash or any sign of an allergic reaction — like increased redness, swelling, or itching at or near the application site. If that happens, stop usin...
  • What should I watch out for while using it?
📖 Read our full Neomycin Topical guide →

🕸️ Concept Web — How Neomycin sulfate 0.005 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Neomycin sulfate 0.005 MG/MG Topical Ointment RxCUI 1544556

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Neomycin 7299
    • Neomycin sulfate 7300
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Neomycin Topical Ointment 373017
    • Neomycin sulfate Topical Ointment 2646201
    • Neomycin Topical Product 1157554
    • Neomycin sulfate Topical Product 2659366
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Neomycin sulfate 0.005 MG/MG 1191342

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Neomycin sulfate 0.005 MG/MG SCDC · 1191342
  • Neomycin Topical Ointment SCDF · 373017
  • Neomycin sulfate Topical Ointment SCDFP · 2646201
  • Neomycin Topical Product SCDG · 1157554
  • Neomycin sulfate Topical Product SCDGP · 2659366

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1544556 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
48201-0104-40 40 g in 1 JAR (48201-104-40) POMADA SULFA FIRST AID ANTIBIOTIC GRANDALL DISTRIBUTING, LLC 2024-07-18
54312-0019-31 1 TUBE in 1 CARTON (54312-019-31) / 28 g in 1 TUBE VITACILINA NEOMYCIN SULFATE FIRST AID ANTIBIOTIC Compania Internacional de Comercio, S.A.P.I de C.V. 2016-07-30
54312-0019-35 1 TUBE in 1 CARTON (54312-019-35) / 14 g in 1 TUBE VITACILINA NEOMYCIN SULFATE FIRST AID ANTIBIOTIC Compania Internacional de Comercio, S.A.P.I de C.V. 2016-07-30
67777-0218-01 1000 BOX in 1 CASE (67777-218-01) / 10 PACKET in 1 BOX (677... Neomycin Dynarex Corporation 2024-01-30
67777-0218-03 1800 BOX in 1 CASE (67777-218-03) / 25 PACKET in 1 BOX (677... Neomycin Dynarex Corporation 2024-01-30
Observed labelers: Compania Internacional de Comercio, S.A.P.I de C.V. (2) · Dynarex Corporation (2) · GRANDALL DISTRIBUTING, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.